Form 4 for TRLV Trulieve Cannabis Corp.
Accepted 2026-06-22 18:04:44 ET · period of report 2026-06-17 · accession 0001213900-26-070732 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MT | 2026-06-22 18:04 | 2026-06-17+ | TRLV | Rivers Kim A. | COB, CEO, Dir, 10% | S - Sale | $9.39 | -482.2K | 2.69M | -15% | -$4.53M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Subordinate Voting Shares | 2026-06-17 | S | D | 137,535 | $9.36 | 3,038,385 | D | — | — | (F1) This transaction was effected pursuant to a Rule 10b5-1 plan to sell 2.5 million shares adopted by the reporting person on March 16, 2026. A Form 144 covering the first tranche of 1,699,007 subordinate voting shares was filed on June 17, 2026. The second tranche of remaining shares will be eligible for sale after September 15, 2026. (F2) Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $9.11 to $9.65. The reporting person has provided to the issuer, and undertakes to provide to the staff of the Commission or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range. |
| 2 | Common | Subordinate Voting Shares | 2026-06-18 | S | D | 139,846 | $9.46 | 2,898,539 | D | — | — | (F1) This transaction was effected pursuant to a Rule 10b5-1 plan to sell 2.5 million shares adopted by the reporting person on March 16, 2026. A Form 144 covering the first tranche of 1,699,007 subordinate voting shares was filed on June 17, 2026. The second tranche of remaining shares will be eligible for sale after September 15, 2026. (F3) Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $9.27 to $9.72. The reporting person has provided to the issuer, and undertakes to provide to the staff of the Commission or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range. |
| 3 | Common | Subordinate Voting Shares | 2026-06-22 | S | D | 204,815 | $9.35 | 2,693,724 | D | — | — | (F1) This transaction was effected pursuant to a Rule 10b5-1 plan to sell 2.5 million shares adopted by the reporting person on March 16, 2026. A Form 144 covering the first tranche of 1,699,007 subordinate voting shares was filed on June 17, 2026. The second tranche of remaining shares will be eligible for sale after September 15, 2026. (F4) Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $9.22 to $9.52. The reporting person has provided to the issuer, and undertakes to provide to the staff of the Commission or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range. (F5) The reporting person also holds Multiple Voting Shares convertible into Subordinate Voting Shares as reported on Table II of this Form 4. |